Veradigm Net Income 2010-2022 | MDRX
Veradigm net income from 2010 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Veradigm Annual Net Income (Millions of US $) |
|
|---|---|
| 2022 | $-86 |
| 2021 | $140 |
| 2020 | $696 |
| 2019 | $-182 |
| 2018 | $364 |
| 2017 | $-196 |
| 2016 | $-26 |
| 2015 | $-2 |
| 2014 | $-66 |
| 2013 | $-104 |
| 2012 | $-1 |
| 2011 | $74 |
| 2010 | $-6 |
| 2010 | $63 |
| 2009 | $26 |
| Veradigm Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-60 |
| 2022-09-30 | $15 |
| 2022-06-30 | $-64 |
| 2022-03-31 | $23 |
| 2021-12-31 | $92 |
| 2021-09-30 | $16 |
| 2021-06-30 | $22 |
| 2021-03-31 | $9 |
| 2020-12-31 | $723 |
| 2020-09-30 | $1 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-20 |
| 2019-12-31 | $-19 |
| 2019-09-30 | $-6 |
| 2019-06-30 | $-150 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $375 |
| 2018-09-30 | $-36 |
| 2018-06-30 | $65 |
| 2018-03-31 | $-40 |
| 2017-12-31 | $6 |
| 2017-09-30 | $-29 |
| 2017-06-30 | $-154 |
| 2017-03-31 | $-20 |
| 2016-12-31 | $-7 |
| 2016-09-30 | $-10 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $2 |
| 2015-12-31 | $16 |
| 2015-09-30 | $-5 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-26 |
| 2014-06-30 | $-18 |
| 2014-03-31 | $-21 |
| 2013-12-31 | $-21 |
| 2013-09-30 | $-49 |
| 2013-06-30 | $-23 |
| 2013-03-31 | $-12 |
| 2012-12-31 | $-24 |
| 2012-09-30 | $9 |
| 2012-06-30 | $8 |
| 2012-03-31 | $6 |
| 2011-12-31 | $26 |
| 2011-09-30 | $19 |
| 2011-06-30 | $16 |
| 2011-03-31 | $13 |
| 2010-12-31 | $-6 |
| 2010-09-30 | $1 |
| 2010-06-30 | $13 |
| 2010-05-31 | |
| 2010-03-31 | $19 |
| 2010-02-28 | $18 |
| 2009-12-31 | |
| 2009-11-30 | $16 |
| 2009-09-30 | $13 |
| 2009-08-31 | $13 |
| 2009-05-31 | |
| 2009-02-28 | $13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.476B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
| Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
| Tempus AI (TEM) | United States | $10.830B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
| Privia Health (PRVA) | United States | $2.787B | 190.50 |
| Enovis (ENOV) | United States | $1.803B | 10.05 |
| Clover Health Investments (CLOV) | United States | $1.623B | 0.00 |
| Schrodinger (SDGR) | United States | $1.570B | 0.00 |
| Phreesia (PHR) | United States | $1.431B | 0.00 |
| Omnicell (OMCL) | United States | $1.322B | 23.33 |
| Azenta (AZTA) | United States | $1.236B | 57.45 |
| 10x Genomics (TXG) | United States | $1.006B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
| Talkspace (TALK) | United States | $0.472B | 141.00 |
| Claritev (CTEV) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.00 |
| Standard BioTools (LAB) | United States | $0.350B | 0.00 |
| Outset Medical (OM) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.190B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.125B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.21 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |